Martha Goldberg Aronson - 02 Jun 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Martha Goldberg Aronson by Power of Attorney
Issuer symbol
CNMD
Transactions as of
02 Jun 2025
Net transactions value
$0
Form type
4
Filing time
04 Jun 2025, 17:29:03 UTC
Previous filing
04 Jun 2024
Next filing
07 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aronson Martha Goldberg Director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/ Thomas Fistek for Martha Goldberg Aronson by Power of Attorney 04 Jun 2025 0001429832

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +479 +4% $0.000000 12,391 03 Jun 2025 Direct
holding CNMD Common Stock 2,000 02 Jun 2025 by IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Award $0 +8,061 $0.000000 8,061 02 Jun 2025 Common Stock 8,061 $55.38 Direct F1
transaction CNMD RSUs (Restricted Stock Units) Award $0 +668 $0.000000 668 02 Jun 2025 Common Stock 668 $0.000000 Direct F2
transaction CNMD RSUs (Restricted Stock Units) Options Exercise $0 -479 -100% $0.000000 0 03 Jun 2025 Common Stock 479 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.